1. Home
  2. MUSA vs NUVL Comparison

MUSA vs NUVL Comparison

Compare MUSA & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Murphy USA Inc.

MUSA

Murphy USA Inc.

N/A

Current Price

$396.23

Market Cap

8.1B

ML Signal

N/A

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

N/A

Current Price

$100.70

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MUSA
NUVL
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
7.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MUSA
NUVL
Price
$396.23
$100.70
Analyst Decision
Buy
Strong Buy
Analyst Count
7
15
Target Price
$450.83
$135.00
AVG Volume (30 Days)
326.1K
542.9K
Earning Date
02-04-2026
02-26-2026
Dividend Yield
0.63%
N/A
EPS Growth
N/A
N/A
EPS
24.10
N/A
Revenue
$17,017,900,000.00
N/A
Revenue This Year
$5.53
N/A
Revenue Next Year
$2.08
N/A
P/E Ratio
$16.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$345.23
$55.54
52 Week High
$523.09
$113.02

Technical Indicators

Market Signals
Indicator
MUSA
NUVL
Relative Strength Index (RSI) 37.03 47.89
Support Level $383.51 $99.97
Resistance Level $457.58 $108.88
Average True Range (ATR) 16.74 4.62
MACD -4.55 -0.40
Stochastic Oscillator 13.82 21.39

Price Performance

Historical Comparison
MUSA
NUVL

About MUSA Murphy USA Inc.

Murphy USA operates more than 1,700 fueling stations and convenience stores primarily across the Midwest and Southeastern United States. The firm owns about 75% of its locations, with most stores situated in high-traffic areas near Walmart supercenters. Murphy's stores typically range from 1,400-2,800 square feet, with most of its in-store sales derived from tobacco and nicotine products. The company acquired about 150 QuickChek stores in 2021, boosting its presence in grocery and foodservice. Murphy generates about two thirds of its profit from fuel retailing, with the remaining third coming from in-store sales.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: